Dr. Julian C. Hong, MD, MS

Dr. Hong practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Hong's NPI, 1235540469, was assigned on May 9, 2014. Dr. Hong graduated from University of Wisconsin-Madison in 2014. Dr. Hong holds California license 161783.

Dr. Hong's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Hong's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Hong is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hong to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hong practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hong's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hong is board certified in clinical informatics by the American Board of Preventive Medicine. Dmand AI has Dr. Hong's licenses on file in 2 states: California and North Carolina.

Dmand AI lists bladder cancer radiation, bone cancer radiation and prostate cancer radiation among the conditions Dr. Hong treats.

CMS data shows 1,662 Medicare services from Dr. Hong across 15 procedure codes in 2024, for 273 Medicare patients. Medicare paid $134,751 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 273 Medicare patients who saw Dr. Hong in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have cancer, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hong's median patient age at 74, with 7% women.

In 2024, Dr. Hong wrote 152 Medicare Part D claims for 54 patients. 93% of them were for generic drugs. CMS names the drug for 124 of them, across 3 drugs with 11 or more claims each, at $2,775 in total drug cost. In 2023, CMS named 151 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hong for performance year 2024, reported as part of a group. Dr. Hong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hong as offering telehealth.

Dmand AI links 74 papers to Dr. Hong, published from 2010 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Chemoradiotherapy, Lung Neoplasms and Machine Learning. Dr. Hong has published most often in Int J Radiat Oncol Biol Phys. Dr. Hong's most frequent co-authors are Manisha Palta, MD, Joseph Kamel Salama, MD and Junzo Paul Chino, MD.

Dmand AI links Dr. Hong to 1 clinical trial.

CMS Open Payments shows 6 general payments to Dr. Hong from 1 drug or device company in 2019. Travel and lodging make up the largest share, 92% of the total. Varian Medical Systems, Inc. paid the most, $688.

Dr. Hong serves on NRG Cancer Care Delivery Research Committee.

Dr. Hong graduated from University of Wisconsin-Madison in 2014. Dr. Hong is a member of American College of Radiation Oncology, ACR, ASTRO and RSNA.

Dr. Hong is in network with 7 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.